Pharma execs urge cooperation, not patent waivers

The pharmaceutical industry has shown leadership and resolve in providing vaccines for COVID-19. The industry is ready to continue working with the administration, world leaders, manufacturers, and suppliers to scale production to continue making a positive impact in fighting COVID-19 around the world.

BioCT encourages the Biden Administration to work WITH the pharmaceutical industry, NOT set harmful precedents.

We applaud the recent letter to President Biden from BIO’s President & CEO, Dr. Michelle McMurry-Heath. In the letter, BIO suggests the establishment of a COVID Global Strategy for Harnessing Access Reaching Everyone (SHARE) Program, to be implemented immediately … more

In a recent interview, Pfizer CEO Albert Bourla warns that waiving patent protections for COVID vaccines would set off a worldwide race for raw materials that threatens the safe and efficient manufacturing of vaccines … more